PAXMEDICA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7398 USD | +5.06% |
|
-2.77% | -2.27% |
Valuation
| Fiscal Period: December | 2023 | 2024 |
|---|---|---|
| Capitalization 1 | 3.429 | 5.523 |
| Enterprise Value (EV) 1 | 3.429 | 5.523 |
| P/E ratio | -0.07 x | -0.69 x |
| Yield | - | - |
| Capitalization / Revenue | - | - |
| EV / Revenue | - | - |
| EV / EBITDA | - | - |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Price to Book | - | - |
| Nbr of stocks (in thousands) | 4,530 | 7,466 |
| Reference price 2 | 0.7570 | 0.7398 |
| Announcement Date | 3/11/24 | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2023 | 2024 |
|---|---|---|
| Net sales 1 | - | - |
| EBITDA | - | - |
| EBIT 1 | -16.15 | -12.2 |
| Operating Margin | - | - |
| Earnings before Tax (EBT) 1 | -18.29 | -12.2 |
| Net income 1 | -18.29 | -12.2 |
| Net margin | - | - |
| EPS 2 | -11.00 | -1.080 |
| Free Cash Flow | - | - |
| FCF margin | - | - |
| FCF Conversion (EBITDA) | - | - |
| FCF Conversion (Net income) | - | - |
| Dividend per Share | - | - |
| Announcement Date | 3/11/24 | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|
| Net sales | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| EBIT | -4.386 | - | - | - | - |
| Operating Margin | - | - | - | - | - |
| Earnings before Tax (EBT) | -5.92 | - | - | - | - |
| Net income | -5.92 | - | - | - | - |
| Net margin | - | - | - | - | - |
| EPS 1 | - | -0.4300 | -0.3000 | -0.2200 | -0.2100 |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 3/11/24 | - | - | - | - |
1USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2023 | 2024 |
|---|---|---|
| Net Debt | - | - |
| Net Cash position | - | - |
| Leverage (Debt/EBITDA) | - | - |
| Free Cash Flow | - | - |
| ROE (net income / shareholders' equity) | - | - |
| ROA (Net income/ Total Assets) | - | - |
| Assets 1 | - | - |
| Book Value Per Share | - | - |
| Cash Flow per Share | - | - |
| Capex | - | - |
| Capex / Sales | - | - |
| Announcement Date | 3/11/24 | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.7398
USD
Average target price
3
USD
Spread / Average Target
+305.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.27% | 5.52M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- PXMD Stock
- Financials PaxMedica, Inc.
